申请人:BADIGER Sangamesh
                            
                            
                                公开号:US20120165331A1
                            
                            
                                公开(公告)日:2012-06-28
                            
                            The invention relates to compounds of the formula I
A-D-C(R
1
)
2
—B  (I),
in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
                            该发明涉及公式IA-D-C(R1)2—B中的化合物  (I),其中取代基如规范中所定义;以自由形式或盐形式存在;以及其制备、用作药物和包含它的药物的用途。